Sunandana Chandra, MD, Northwestern Medicine
Articles
Treatment Optimization for Patients With Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Future Treatment Landscape for Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Promising Late-Stage Trials in Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Targeted Therapy Versus IO for Relapsed/Refractory Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Novel Approaches for Relapsed/Refractory Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Management of Brain Metastases in Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
I/O Dosing Schedules in Metastatic Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Novel Therapies for Metastatic Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Systemic Therapy for Metastatic Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Adjuvant Therapy for Melanoma: Safety and Efficacy
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Adjuvant Therapy for Melanoma: Ongoing Studies of Interest
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Adjuvant Data Explored for Locally Advanced Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Neoadjuvant Data Explored for Locally Advanced Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
pCR and Neoadjuvant Therapy for Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Molecular Testing in Locally Advanced Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Identifying Patients for Neoadjuvant Melanoma Therapy
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Optimal Management of Locally Advanced Melanoma
Jeffrey S. Weber, MD, PhD, NYU Langone Health;Sunandana Chandra, MD, Northwestern Medicine;Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center;Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center;Ryan J. Sullivan, MD, Massachusetts General Hospital Cancer Center
June 23rd 2020Read More
Latest Updated Articles
Published: July 9th 2024 | Updated: July 10th 2024
Dr Rafiq on Novel Strategies for CAR T-Cell Engineering in Solid Tumors
Published: June 2nd 2024 | Updated: June 3rd 2024
Perioperative Chemotherapy Prolongs OS vs Neoadjuvant Chemoradiation in Esophageal Cancer
Published: July 25th 2024 | Updated: July 27th 2024
Dr Rotow on the Impact of Biomarker Testing on NSCLC Treatment Outcomes
Published: July 25th 2024 | Updated: July 27th 2024
Dr Sabari on Barriers to Biomarker Testing in NSCLC
Published: July 18th 2024 | Updated: July 27th 2024
Treatment Considerations and Patient Selection for CAR T-cell Therapy in R/R ALL
Published: July 18th 2024 | Updated: July 27th 2024
Expert Insights on ZUMA-3 Data Updates: 4-Year Follow-up and Real World Data
